Results 211 to 220 of about 56,049 (248)

An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in Rat. [PDF]

Drug Des Devel Ther
Li H, Wu H, Gao S, Cui L, Xu J, Sun J, Liu Z, Wang Z, Tao X.   +8 more
europepmc   +1 more source

Protective Effects of Policosanol and Atorvastatin Co-Supplementation Against High-Cholesterol and High-Galactose Diet-Induced Metabolic and Organ Dysfunction in Zebrafish. [PDF]

Int J Mol Sci
Cho KH, Jeon C, Bahuguna A, Kim JE, Lee SH, Lee Y, Baek SH.   +6 more
europepmc   +1 more source

Gene regulatory network analysis identifies auranofin as an anti-atherosclerotic drug. [PDF]

Nat Commun
Amadori L, Calcagno C, Kaur R, Horstmann H, He T, Gildea M, Sakurai K, Chong PS, Shamailova R, Naidu S, Hill CA, Sajja S, Bresciani J, La Forest M, Ghotbi AA, Soler R, Faries C, Fisher EA, Fayad ZA, Fillmore NR, Ramos-Cejudo J, Readhead B, Dudley JT, Bjorkegren JLM, Giannarelli C.   +24 more
europepmc   +1 more source

A ROS‑responsive liposome for atherosclerosis treatment via combined regulation of lipid metabolism and CD47 blockade. [PDF]

Int J Pharm X
Yuan P, Tian S, Cui C, Sun C, Tang C, Gao D, Lu L, Long K, Xu F, Shu G, Zhang W, Liang X, Kong F, Li M, Li H.   +14 more
europepmc   +1 more source

Atorvastatin

Expert Opinion on Pharmacotherapy, 2005
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic vascular disease. By lowering lipid levels and reducing the risk of coronary heart disease, these drugs are among the most effective at reducing morbidity and mortality available to clinical practice.
Sander I, van Leuven, John J P, Kastelein   +1 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Atorvastatin

Drugs, 2007
Extensive data are available on the safety of atorvastatin from randomised clinical trials, postmarketing analyses and reports to regulatory agencies. Atorvastatin is generally well tolerated across the range of therapeutic dosages, with the exception of a slightly higher rate of liver enzyme elevations with atorvastatin 80 mg/day which does not appear
openaire   +3 more sources